Cisplatin dose rate as a risk factor for nephrotoxicity in children
1998

Cisplatin Dose Rate and Nephrotoxicity in Children

Sample size: 35 publication Evidence: moderate

Author Information

Author(s): R Skinner, ADJ Pearson, MW English, L Price, RA Wyllie, MG Coulthard, AW Craft

Primary Institution: Sir James Spence Institute of Child Health, University of Newcastle upon Tyne

Hypothesis

Does the dose rate of cisplatin affect the incidence and severity of nephrotoxicity in children?

Conclusion

Cisplatin nephrotoxicity is more severe in children receiving higher dose rates, but some recovery of kidney function occurs over time.

Supporting Evidence

  • 58% of children had a GFR below the normal range.
  • 29% of children were hypomagnesaemic after treatment.
  • Nephrotoxicity scores were significantly lower in children receiving lower dose rates of cisplatin.

Takeaway

This study found that giving cisplatin at a slower rate is better for kids' kidneys. Even though some kids got better, we still don't know how long the kidney problems might last.

Methodology

The study measured glomerular filtration rate (GFR) and tubular function in children after cisplatin chemotherapy, comparing those who received low and high dose rates.

Limitations

The long-term outcomes of nephrotoxicity remain unknown, and the study had a limited follow-up period.

Participant Demographics

Children aged 0.6 to 17.8 years, with various types of cancers including neuroblastoma and brain tumors.

Statistical Information

P-Value

p<0.005

Statistical Significance

p<0.005

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication